Solasia completes IPO

On March 24, cancer company Solasia Pharma K.K. (Tokyo:4597) raised ¥3.6 billion ($33.1 million) through the sale of 19.4 million shares at ¥185 in an IPO on Tokyo Stock Exchange's Mothers. The offer...